latest news releases from the newsroom
Generex Biotechnology Corp.
Generex to Present Positive Study Data At American Diabetes Association Scientific Sessions 2009
WORCESTER, Mass., June 4, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that data in respect of two of its products will be presented at the American Diabetes Association's (ADA's) 69th Annual Scientific Sessions being held in New Orleans from June 5 to 9. The annual meeting of the ADA (www.diabetes.org) is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and diabetes care.
Hemispherx Biopharma, Inc.
Japanese National Institute of Infectious Diseases Scientists Identify Hemispherx Biopharma's Drug Technology as the "Most Promising Mucosal Adjuvant for Influenza"
PHILADELPHIA, June 4, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced today that a new peer reviewed publication titled "Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses" was published in Therapeutics and Clinical Risk Management 2009:5 125-132. The article summarizes ongoing research in which researchers conclude that Poly I:PolyC12U (Ampligen(r)), an experimental therapeutic, is the "most promising adjuvant candidate for mucosal vaccines." Poly I:PolyC12U (Ampligen(r)), an experimental therapeutic, was also "extremely important" in these studies, in that it produced cross-protection against variant influenza viruses not seen with the vaccines given alone.
Purple Communications, Inc.
Purple(TM) Appoints Dominic A. Gomez President
NOVATO, Calif., June 4, 2009 -- Purple Communications(TM), Inc. ("Purple") (Nasdaq:PRPL) , one of the nation's leading providers of video and text relay and on-site interpreting services, today announced the appointment of Dominic A. Gomez as the Company's new president. Gomez will be an integral member of the Company's executive management team, reporting to Purple Communications chief executive officer, Dan Luis.
Cree Announces Strategic Relationship With RFHIC
DURHAM, N.C., June 4, 2009 (GLOBE NEWSWIRE) -- Cree, Inc. (Nasdaq:CREE) announced today that it has signed a definitive agreement with RFHIC Corporation (Suwon, Korea) for Cree to supply GaN-on-SiC transistors to RFHIC for their GaN HEMT amplifier product families. In addition, Cree and RFHIC have entered into a market development agreement to facilitate deeper market penetration of GaN HEMT solutions by leveraging Cree's expertise in GaN transistor production on SiC and its MMIC foundry capability and RFHIC's leadership position in innovative packaging, amplifier integration and volume assembly capabilities.